Boehringer Ingelheim opens new Respimat manufacturing facility

Boehringer Inhgelheim has opened a new €120 million Respimat manufacturing facility in Sant Cugat del Vallés, Spain, near Barcelona, the company said. The 17,000 sq m plant is expected to produce 25 million units per year, over half of Respimat global annual sales. The facility will create approximately 200 new jobs.

Boehringer Ingelheim Spain CEO Peter Ploeger commented, “The inauguration of this new plant is the recognition of the excellence and professionalism of hundreds of workers who, with their dedication, effort and commitment, have positioned the Boehringer Ingelheim facilities in Sant Cugat as one of the Group’s innovation hubs in Europe and a world benchmark for its excellence and standards of quality and care for the environment.” (Google translation from Spanish)

In April 2019, BI announced that it had completed expansion of Respimat manufacturing facilities in Dortmund and Ingelheim, Germany.

Read the Boehringer Ingelheim Spain press release (in Spanish).

Share

published on

May 10-May 14RDD 2026, Phoenix, AZ, USA

May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA

May 17-May 20: ATS International Conference 2026, Orlando, FL, USA

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan